<DOC>
	<DOCNO>NCT00630045</DOCNO>
	<brief_summary>This study aim discuss efficacy safety neoadjuvant chemotherapy XELOX regimen ( oxaliplatin plus capecitabine ) .</brief_summary>
	<brief_title>Phase 3 Study Surgery Combined With Neoadjuvant Chemotherapy ( XELOX ) Colorectal Cancer With Resectable Liver Metastasis</brief_title>
	<detailed_description>Liver metastasis important prognostic factor colorectal cancer . Reasonable multidisciplinary therapy might improve prognosis patient liver metastasis . Surgery first choice situation . Recently , neoadjuvant chemotherapy also show value unresectable liver metastasis , increase chance R0 resection give clue chemosensitivity agent . However , resectable lesion , role safety neoadjuvant chemotherapy yet confirm . design study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>1 . Histologically confirm colorectal cancer liver metastasis ( patient pathological report colorectal cancer . The chance hepatocellular carcinoma metastasis primary lesion exclude . ) 2 . Liver metastasis resect R0 resection save enough normal liver tissue 3 . Anticipated liver resection : normal liver , ﹤70 % ; liver cirrhosis , ﹤50 % 4 . No metastasis organs lymph node abdominal cavity 5 . No previous use oxaliplatin capecitabine , previous adjuvant treatment end 6 month 6 . Age 18 75 year old 7 . Karnofsky performance status ≥70 8 . Life expectancy ≥3 month 9 . Bilirubin level &lt; 1.5mg/dL 10 . Serum creatinine &lt; 1.0 time ULN 11 . Absolute neutrophil count ≥2000/mm3 , platelet &gt; 100,000/mm3 , Hb &gt; 9g/dl 12 . Having sign informed consent 1. previous use oxaliplatin fluorouracilbased chemotherapy 6 month . 2 . No R0 resection enough normal liver tissue leave 3. previous radiotherapy target lesion 4. accompany unresectable metastasis malignant pleural fluid ascites . 5. complete uncompleted liver obstruction 6. peripheral neuropathy ( NCICTC grade 1 ) 7. mental disturbance neuropathy influence cognition , include brain metastasis 8. serious disease uncontrollable active infection , heart infarction 1 year , un control hypertension , arrhythmia high risk , unstable heart infarction , heart failure , coronary artery disease , myocardial infarction within last 6 month 9 . Other previous malignancy within 5 year , except nonmelanoma skin cancer 10. accompany antitumor therapy , include immune therapy , intervention injection chemotherapeutical agent serous cavity , participate clinical trial . 11 . Pregnancy lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>